Clearmind Medicine (CMND) Accounts Payables (2021 - 2023)

Clearmind Medicine (CMND) posted quarterly Accounts Payables of $805453.0 for Q2 2023, up 20.59% quarter-over-quarter from $667901.5 in Q1 2023.

Clearmind Medicine (CMND) Accounts Payables (2021 - 2023) Analysis & Trends

Clearmind Medicine's Accounts Payables history runs 3 years deep, the most recent figure standing at $805453.0 for Q2 2023.

In Q2 2023, Accounts Payables changed N/A year-over-year to $805453.0; the TTM figure through Apr 2023 stood at $805453.0 (changed N/A YoY), while the FY2022 annual figure was $1.1 million, up 291.43% from the prior year.
Accounts Payables for Q2 2023 stood at $805453.0, up from $667901.5 in the prior quarter.
The five-year high for Accounts Payables was $1.1 million in Q4 2022, with the low at $277524.3 in Q4 2021.
The 3-year median for Accounts Payables is $736677.2 (2023), against an average of $700660.9.
Peak annual rise in Accounts Payables reached 278.98% in 2022, while the deepest fall reached 278.98% in 2022.
Clearmind Medicine's Accounts Payables stood at $277524.3 in 2021, then surged by 278.98% to $1.1 million in 2022, then decreased by 23.42% to $805453.0 in 2023.
Business Quant data shows CMND's Accounts Payables at $805453.0 in Q2 2023, $667901.5 in Q1 2023, and $1.1 million in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Accounts Payables (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	429.50 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	1.16 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	1.52 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	167.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	470.30 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	108.02 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	622.65 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	428.93 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	35.57 Mn
10	Clearmind Medicine	537,435.54	-13.06 Mn	-	-

Download Data